Asia Pacific Insulin Pens Market to 2027 - Regional Analysis and Forecasts by Product Type (Disposable and Reusable); Application (Diabetes Type-1 and Diabetes Type-2); Distribution Channel (Hospital Pharmacies, Retail Pharmacies and e-Commerce) and Geography
The Asia Pacific insulin pen market is expected to reach US$ 1,703.7 Mn in 2027 from US$ 743.4 Mn in 2018. The market is estimated to grow with a CAGR of 9.8% from 2019-2027.
The growth of the market is driven by the factors such as, growing geriatric population, increasing rate of obesity and rising incidence of diabetes. However, the market is likely to get impacted due to availability of alternatives for drug delivery and limitations associated with insulin pens in the region.
Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two types of diabetes namely diabetes type-I also known as diabetes insipid us and diabetes type-II also termed as diabetes mellitus. Incidences and prevalence of diabetes is steadily increasing across the globe. Type 2 diabetes is the most prevalent form of diabetes and has increased alongside cultural and societal changes. In high-income countries up to 91% of adults with the disease have type 2 diabetes.
According to the International Diabetes Federation estimated that there were 382 million people with diabetes in 2013, a number exceeding its earlier predictions. Here, more than 60% of the people with diabetes live in Asia, with almost one-half in China and India combined. The Western Pacific is the world’s most populous region, has more than 138.2 million people with diabetes, and the number may rise to 201.8 million by 2035.
PREVALENCE OF DIABETES WORLDWIDE, 2017
Country | People with Diabetes |
China | 114,394.82 |
Japan | 7,234.23 |
India | 72,946.39 |
Source: International Diabetes Federation
Diabetes of all types can lead to various complications in many parts of the body and can increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss and nerve damage are the major complications associated with this disease.
Patients suffering from diabetes require frequent monitoring and external administration of insulin that is given through insulin pens and other medical devices. The rising prevalence of diabetes across the globe is expected to drive the growth of the insulin pens market worldwide during the forecast period.
China is expected to lead the market in the Asia Pacific region owing to highest rate of incidences for the type 2 diabetes and increasing awareness in the country. However, rise in the prevalence of the diabetes is likely to add novel opportunities in the forecast period. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.
ASIA PACIFIC DIABETES CARE DEVICES – MARKET SEGMENTATION
By Product
- Disposable
- Reusable
By End User
- Diabetes Type-1
- Diabetes Type-2
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
By Geography
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
Company Profiles
- Owen Mumford, LTD.
- Novo Nordisk a/s
- Companion Medical
- Berlin-Chemie AG
- Pendiq GmbH
- Emperra GmbH E-Health Technologies
- Eli lilly and company
- Ypsomed Ag
- SANOFI
- Biocon
Part 1.Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
Part 2.North America Diabetes Care Devices Market – Key Takeaways
Part 3.North America Diabetes Care Devices Market – Market Landscape
3.1 Overview
3.2 Market segmentation
3.2.1 North America Diabetes Care Devices Market – By Product
3.2.2 North America Diabetes Care Devices Market – By End USer
3.2.3 North America Diabetes Care Devices Market – By Country
3.3 PEST Analysis
Part 4.North America Diabetes Care Devices Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Growing Geriatric Population
4.1.2 Rapid Technological Advancements in Diabetes Care Devices
4.2 Key Market Restraints
4.2.1 High Cost of Diabetes Care Devices
4.2.2 Risks Associated with the Insulin Delivery Devices
4.3 Key Market Opportunities
4.3.1 Development of Cost Efficient Pen Needles
4.4 future Trends
4.4.1 Growing Product Innovations
4.5 Impact analysis
Part 5.Diabetes Care Devices Market – North America Analysis
5.1 North America DIABETES CARE DEVICES market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
5.3.1 Medtronic
5.3.2 F. Hoffmann-La Roche Ltd.
Part 6.North America Diabetes Care Devices Market Analysis – By Product
6.1 overview
6.2 North America diabetes care devices Market BY Product, 2018 & 2027 (%)
6.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)
6.3.1 North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
6.3.2 North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
6.4 Glucose Monitoring Devices Market
6.4.1 Overview
6.4.2 North America Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.4.3 Glucometers Market
6.4.3.1 Overview
6.4.3.2 North America Glucometers Market Revenue and Forecast to 2027 (US$ Mn)
6.4.4 Lancets Market
6.4.4.1 Overview
6.4.4.2 North America Lancets Market Revenue and Forecast to 2027 (US$ Mn)
6.4.5 Testing Strips Market
6.4.5.1 Overview
6.4.5.2 North America Testing Strips Market Revenue and Forecast to 2027 (US$ Mn)
6.4.6 Other Glucose Monitoring Devices Market
6.4.6.1 Overview
6.4.6.2 North America Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Insulin Delivery Devices Market
6.5.1 Overview
6.5.2 North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3 Insulin Pens Market
6.5.3.1 Overview
6.5.3.2 North America Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4 Insulin Syringes Market
6.5.4.1 Overview
6.5.4.2 North America Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn)
6.5.5 Insulin Pumps Market
6.5.5.1 Overview
6.5.5.2 North America Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn)
6.5.6 Other Insulin Delivery Devices Market
6.5.6.1 Overview
6.5.6.2 North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)
Part 7.North America Diabetes Care Devices Market Analysis – By End USer
7.1 Overview
7.2 NORTH AMERICA DIABETES CARE DEVICES MARKET, BY End USer, 2018 & 2027 (%)
7.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)
7.4 Homecare MArket
7.4.1 Overview
7.4.2 North America Homecare Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Hospitals & Clinics Market
7.5.1 Overview
7.5.2 North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
Part 8.North America Diabetes Care Devices Market Revenue And Forecasts To 2027
8.1 Overview
8.2 North America DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.1 North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2 North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.5 North America Diabetes care devices Market Revenue And Forecasts to 2027, By Country (%)
8.6 US DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.6.1 US Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.2 US Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.6.2.1 US Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.2.2 US Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.3 US Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.7 Canada Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.1 Canada Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.2 Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.7.2.1 Canada Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.2.2 Canada Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.3 Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.8 Mexico Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.1 Mexico Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.2 Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.8.2.1 Mexico Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.2.2 Mexico Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.3 Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
Part 9.Diabetes Care Devices Market – Industry Landscape
9.1 Overview
9.2 Comparative Company Analysis
9.3 Growth Strategies done by the companies in the Market, (%)
9.4 Organic Developments
9.4.1 Overview
9.5 Inorganic developments
9.5.1 Overview
Part 10.Diabetes Care Devices Market–Key Company Profiles
10.1 BD
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 novo nordisk a/s
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Overview
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 B. Braun Melsungen AG
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Medtronic
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Information
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Tandem Diabetes Care, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Insulet Corporation
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Information
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Eli lilly and company
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Dexcom, Inc.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Terumo Corporation
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product portfolio
10.9.5 SWOT ANALYSIS
10.9.6 KEY DEVELOPMENTS
10.10 F. Hoffmann-La Roche Ltd.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
Part 11.Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
LIST OF TABLES
Table 1. Total Number Of Persons Ofaged 60 Years Or Above By Region, 2017 & 2050
Table 2. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 3. North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 4. North America Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 5. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)
Table 6. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 7. North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 8. North America Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 9. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)
Table 10. US Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 11. US Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 12. US Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 13. US Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)
Table 14. Canada Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 15. Canada Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 16. Canada Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 17. Canada Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)
Table 18. Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 19. Mexico Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 20. Mexico Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 21. Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)
Table 22. Organic Developments Done By Companies
Table 23. Inorganic Developments Done By Companies
Table 24. Glossary Of Terms, Diabetes Care Devices Market
LIST OF FIGURES
Figure 1. US Diabetes Care Devices Market, Revenue (US$ Mn), By Country 2018 & 2027
Figure 2. North America Diabetes Care Devices Market By Product, Market Share (%), 2018
Figure 3. North America Diabetes Care Devices Market By End USer, Market Share (%), 2018
Figure 4. Diabetes Care Devices Market Segmentation
Figure 5. North America Pest Analysis
Figure 6. Diabetes Care Devices Market Impact Analysis Of Drivers & Restraints
Figure 7. North America Diabetes Care Devices Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 8. North America Diabetes Care Devices Market, By Product 2018 & 2027 (%)
Figure 9. North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 10. North America Glucometers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 11. North America Lancets Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 12. North America Testing Strips Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 13. North America Other Glucose Monitoring Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 14. North America Insulin Delivery Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 15. North America Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 16. North America Insulin Syringes Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 17. North America Insulin Pumps Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 18. North America Insulin Delivery Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. North America Diabetes Care Devices Market By End USer, 2018 & 2027 (%)
Figure 20. North America Homecare Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 21. North America Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 22. North America Diabetes Care Devices Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 23. North America Diabetes Care Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Country (%)
Figure 25. US Diabetes Care Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 26. Canada Diabetes Care Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Comparative Company Analysis
Figure 29. Growth Strategies Done By The Companies In The Market, (%)
The List of Companies
- Owen Mumford, LTD.
- Novo Nordisk a/s
- Companion Medical
- Berlin-Chemie AG
- Pendiq GmbH
- Emperra GmbH E-Health Technologies
- Eli lilly and company
- Ypsomed Ag
- SANOFI
- Biocon